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Abstract 
Bleeding stomal varices are often difficult to manage given the comorbidities that are associ-
ated with their presentation. Here, we report a case of a 62-year-old female with stomal vari-
ceal hemorrhage in the setting of chronic portal vein thrombosis who was ineligible for 
transhepatic intrajugular portosystemic shunt or surgery as a result of her challenging anatomy 
and peri-operative risks. Despite coil embolization, this patient experienced refractory bleeds 
which ceased following the initiation of a non-selective beta-blocker (NSBB). This case provides 
further evidence for the expanding role of NSBBs as an important therapeutic agent for com-
plicated ectopic varices. © 2021 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Stomal varices are a rare complication of portal hypertension in the setting of bowel re-
section and are associated with substantially higher risks of bleeding relative to esophageal 
varices [1, 2]. Although there is no standardized therapy, treatment typically involves surgical 
or image-guided interventions for both acute control of bleeding and decompression of portal 
systems [3]. Here, we present a case of in-operable stomal varices with acute hemorrhage 
 
Case Rep Gastroenterol 2021;15:87–91 
DOI: 10.1159/000510921 © 2021 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/crg 






refractory to coil embolization that was successfully managed conservatively with non-selec-
tive beta-blockade. 
Case Presentation 
Mrs. X is a 62-year-old female with an ileostomy from prior hemicolectomy secondary to 
ischemic bowel who presented to our institution with an abrupt episode of painless bright red 
blood per ostomy. This patient has an extensive medical profile including a history of sponta-
neous portal vein thrombosis (PVT) that was complicated by splenic rupture and subsequent 
splenectomy as well as chronic portal hypertension, leading to cavernous transformation of 
stomal and abdominal wall varices. However, the patient was not treated with anticoagulation 
at the time of PVT diagnosis due to concurrent hemorrhagic stroke in the setting of suspected 
thrombocytopenic thrombotic purpura (TTP). She has had extensive investigations in the past 
regarding suspected autoimmunity, but no unifying diagnosis could be made. 
On initial assessment, her hemoglobin (Hb) had dropped to 82 from a baseline of 110. The 
patient was transfused with 2 units of packed red blood cells (pRBCs) and her Hb improved 
subsequently to 104. Soon after, her bleeding ceased spontaneously, and she was admitted to 
the internal medicine service for further workup. 
Once admitted, the patient underwent urgent endoscopic investigations which revealed 
scarring of esophageal varices that had been previously treated with sclerotherapy. The 
source of her hemorrhage was attributed to tortuous and dilated varices found on computed 
tomography (CT) imaging which extended throughout the ostomy defect and into the ostomy 
site (Fig. 1). Shortly after, the patient experienced another episode of substantial hemorrhage 
through her ostomy and underwent emergent coil embolization to several branches of her 
stomal varices, achieving temporary hemostasis. 
The patient experienced two recurrent episodes of major bleed in the days following em-
bolization that required urgent transfusions before spontaneous hemostasis. Throughout her 
admission, the patient was assessed and closely followed by our general surgery team. How-
ever, after extensive discussions among experts, it was deemed that the peri-operative risks 
of surgical interventions were too great to warrant any elective procedure. This decision was 
made in context of a prior elective ileostomy reversal that was abandoned intra-operatively 
due to excessive bleeding. Our experts from vascular surgery, interventional radiology (IR), 
and gastroenterology also conducted independent assessments on the patient but unfortu-
nately, no further surgical, radiological, or endoscopic interventions were deemed feasible for 
the correction of her stomal varices. 
Given the lack of therapeutic options, we initiated the use of non-selective beta-blockade 
after reviewing case reports of its potential efficacy for minimizing recurrent stomal variceal 
hemorrhage in those with non-cirrhotic portal hypertension [3, 4]. Nadolol was started at a 
reduced dose due to patient’s low baseline blood pressure and titrated to 40 mg oral daily as 
tolerated; reaching the targeted 25% decrease in heart rate. The patient was monitored 
closely over the next 2 weeks, while her diet was slowly advanced from nil per os (NPO) to 
diet as tolerated. She did not have any further hemorrhage through her ostomy and was dis-
charged home with a safety plan in place. On follow-up, 3-month post-discharge, the patient 
reported no recurrent bleeds and her Hb was stable at her previous baseline. 
 
Case Rep Gastroenterol 2021;15:87–91 
DOI: 10.1159/000510921 © 2021 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/crg 







NSBBs have been well-described as a frontline therapy for primary and secondary 
prophylaxis of esophageal variceal hemorrhage among cirrhotic patients [5]. Physiologically, 
NSBBs reduces portal hypertension primarily through β-2 antagonism which leads to splanch-
nic vasoconstriction by unopposed α-adrenergic activity [6]. However, the clinical response 
to NSBBs can vary, as only 38% of patients may have significant reductions in their portal 
pressures [7]. Furthermore, the benefits of NSBBs have not been well-characterized for ec-
topic varices where locoregional features play a significant role in their pathogenesis [1]. 
Therefore, the management of ectopic varices should be individualized based on the distinct 
anatomy and clinical context of each patient. 
Stomal varices are a rare form of ectopic varices that carry a high propensity for hemor-
rhage [8]. They are most commonly seen among ileostomized patients with inflammatory 
bowel disease (IBD) and associated primary sclerosing cholangitis (PSC) but may develop in 
any setting of chronic portal hypertension following bowel resection [4, 8]. Various treat-
ments including surgical revision of ostomy, variceal ligation, sclerotherapy, variceal emboli-
zation, and transhepatic intrajugular portosystemic shunt (TIPS) have been used for manage-
ment of stomal varices [3]. The latter – TIPS – has been cited as the preferred modality of 
portal decompression in most cases with consideration for surgical shunting should TIPS fail 
[3]. Although extensive PVT is not an absolute contraindication for TIPS, the presence of 
chronic PVT with cavernous transformation, as in the case of our patient, substantially in-
creased the difficulty of TIPS creation and is associated with a high failure rate [9, 10]. Even 
following successful TIPS, rebleeding rates may be as high as 25% [11]. As a result, some have 
proposed for concurrent embolization at the time of TIPS insertion whenever possible to fur-
ther reduce rebleeding risks [11, 12]. 
Our patient presented us with a challenging clinical scenario. Given her high surgical risks 
and the lack of therapeutic options from an endoscopic and IR perspective, her refractory sto-
mal variceal hemorrhage following coil embolization prompted us to explore any potential 
therapies that may minimize her risks of recurrent bleeds. Interestingly, pharmacological 
therapies have seldomly been explored in the setting of stomal variceal hemorrhage and spe-
cifically, the use of NSBBs has only been described in case studies [3, 4, 13]. While the efficacy 
of NSBBs in this setting has been questioned [3, 14], there have been some reports of its suc-
cess in preventing stomal variceal rebleeds in the absence of TIPS or embolization [4]. How-
ever, it is important to mention that among those treated with NSBB monotherapy as second-
ary prophylaxis, subsequent rebleeds did occur in most instances [3]. 
On average, NSBBs roughly lower hepatic venous portal gradient (HVPG) – a measure of 
portal pressures – by 15% [15]. To put this into perspective, HVPG needs to be reduced to <12 
mm Hg or by ≥20% from baseline in order have substantial benefit as secondary prophylaxis 
for esophageal variceal bleeds [15]. Given that ectopic varices have high propensity to bleed 
even with HVPG <12 mm Hg [8], NSBB therapy alone is unlikely to be sufficient in the preven-
tion of recurrent stomal variceal hemorrhage. However, when used in combination with in-
terventional therapy, NSBBs may reduce the portal pressures enough such that it is below the 
threshold for which rebleeds occur. We suspect this to be the case with our patient who 
showed clinically improvement only after the initiation of NSBB following emergent coil em-
bolization. 
In conclusion, stomal variceal hemorrhage is an uncommon presentation among 
ostomized patients that presents unique clinical challenges for physicians. Although 
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interventional therapies have been the primary treatment options [3], our case highlights an 
increasing role that NSBBs may play as secondary prophylaxis against stomal variceal hemor-
rhage. In the setting of bleeding stomal varices, clinicians should consider the early initiation 
of NSBBs and its adjunctive use with other invasive interventions. 
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Fig. 1. Contrast enhanced axial CT image demonstrates multiple dilated varices surrounding and extending 
through the ostomy site (see arrowhead). 
 
